Wellstar International, Inc.

Wellstar International, Inc. does not have significant operations. Previously, the company, through its subsidiary, Trillennium Medical Imaging, Inc., engaged in developing and licensing advanced thermal imaging technology in the consumer health care markets. Its technology enabled a diagnostic screening procedure for the early breast cancer detection; the differential diagnosis of pain dysfunctions, such as reflex sympathetic dystrophy, neuromuscular skeletal syndromes, and neurological disorders; and the detection of pressure ulcers, deep tissue injuries, and bed sores, as well as orthopedic applications. Wellstar International, Inc. was founded in 1997 and is based in Holland, Ohio.